[ad_1]
Vaccines against the coronavirus could begin in the US before mid-December, said Moncef Slaoui, a senior leader in a government-organized vaccination campaign.
Our plan is to deliver the vaccine at the vaccination sites (.) Within 24 hours after authorization, that is, vaccination can begin on December 11 or 12.
Moncef Slaoui told CNN American News.
Pfizer’s New York-based company and its German partner, BioNTech, filed an application for authorization with the US Food and Drug Administration (FDA) on Friday.
They trust that in the first two weeks of December they may already have the permit.
According to The New York Times, the FDA plans to study the application for three weeks, after which it will be reviewed by independent experts, with its meeting scheduled for December 10.
Pfizer announced Wednesday that it has completed the final phase of clinical testing of its 95 percent efficient ribonucleic acid messenger-based vaccine and expects to produce at least 50 million doses of vaccine this year and 1.3 billion doses in 2021.
They could reach up to 705 million vaccines.
[ad_2]
